Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00968
|
|||||
| Drug Name |
Naltrexone
|
|||||
| Synonyms |
Depotrex; IBS therapy, Pain Therapeutics; Irritable bowel syndrome therapy, Pain Therapeutics; Naltrel; Naltrexone (low-dose), Pain Therapeutics; Naltrexone (once-monthly controlled-release, Medisorb), Alkermes; Naltrexone (polymer microcapsule depot, opioid addiction/alcohol dependency), Biotek; Naltrexone (sustained release), DAS; Naltrexone (sustained release), elbion; Naltrexone (transdermal, alcohol/opioid dependence), Syntropharma; Naltrexone Depot; Naltrexone depot (injectable suspension), DrugAbuse Sciences; Naltrexone depot (injectable suspension), elbion; Opioid antagonists (irritable bowel syndrome), Pain Therapeutics; PTI-901; Vivitrex; Vivitrol; XR-NTX
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C20H23NO4
|
|||||
| Canonical SMILES |
C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O
|
|||||
| InChI |
InChI=1S/C20H23NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,15,18,22,24H,1-2,5-10H2/t15-,18+,19+,20-/m1/s1
|
|||||
| InChIKey |
DQCKKXVULJGBQN-XFWGSAIBSA-N
|
|||||
| Pharmaceutical Properties | Molecular Weight | 341.4 | Topological Polar Surface Area | 70 | ||
| Heavy Atom Count | 25 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
1.9
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.